HIGHLIGHTS
- Who: Saket from the MAFEREB, Commerce Center DrPlymouth, MI, USA Department of and Biomedical Sciences University of Georgia, W have published the Article: Accepted Manuscript (unedited), in the Journal: (JOURNAL)
SUMMARY
Cancer therapeutics has the major challenge of non-selective cellular uptake for cancer cells in cancer therapy. This has resulted in poor prognosis in some types of cancer despite the wide range of cancer treatments currently available. Hybrid nanocarriers in drug delivery are unique nanocarriers that are aimed at harnessing the advantages of two or more nanocarriers and over the drawbacks of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.